Health Care: Drugs

Arrowhead Research Corp (ARWR: NASDAQ)

$5.215 -0.355 | -6.37%
10/13/15 - 03:27 PM ET
Company Profile
Price and Volume
Recent Price 5.57
52 Week High 9.36
52 Week Low 4.35
Avg. Daily Vol. (Mil) 1.84
Beta (3 year) 2.26
Share Related Items
Mkt Cap (Mil) 331.42
Shares Out (Mil) 59.50
Float (Mil) 54.68
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 11.60
Current Ratio 12.00
LT Debt/ Equity 0.00
Total Debt / Equity 0.01
Valuation Ratios
Price Earnings n.a.
Price/Sales 867.59
Price/Book 2.52
Price/Cash Flow -3.80
Per Share Data
Earnings -1.63
Sales 0.01
Book Value 2.21
Cash Flow -1.45
Business Summary
Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.
General Information
225 South Lake Avenue
Suite 1050
Pasedena, CA 91101
Industry : Drugs
Sector: Health Care
Employees: 81
CEO: Dr. Christopher Anzalone
Short Interest
Current Month (Mil) 15.17
Previous Month (Mil) 14.61
Short Interest Ratio (Days) 4.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -61.70
Return on Investments -68.00
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ARWR

Latest ARWR Headlines from TheStreet

More Financial News for ARWR

Press Releases for ARWR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter